Articles On Avita Medical (ASX:AVH)

In just two years, skin regenerator Avita Medical (ASX:AVH) has shot up from 6c to 40c and was granted entry into the ASX 200, but the company says it hasn’t made it yet. Chief financial officer David McIntyre, who joined Avita in November...

The ASX healthcare sector continues to be one of the top performers on the ASX in terms of share price rises. While most Australians are likely familiar with Cochlear Limited (ASX: COH), CSL Limited (ASX: CSL), and Ramsay Health Care Limit...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Australian investors enter the weekend with the ASX 200 (INDEXASX: XJO) falling over 2% on the final day of the week. How much did the ASX 200 fall over this week? Well it finished down 2.8% today to 6,216, which was a fall of 3.5% during...

The S&P/ASX 200 index has given back yesterday’s gains and more. In afternoon trade the benchmark index is down 1.8% to 6,281.3 points. Four shares that have fallen more than most today are listed below. Here’s why they are tumbling lo...

Shares in ASX 200 healthcare group Avita Medical Ltd (ASX: AVH) have had an impressive run in the last 12 months. In the past year, the medical tech group’s shares are up 353.57% higher to $0.64 per share. That means Avita’s market capital...

Regenerative medicine company Avita Medical (ASX: AVH) has commenced what it calls a “pivotal trial” for the treatment of paediatric scald injuries, seeking to demonstrate that its RECELL treatment can safely and effectively increase the in...

The S&P/ASX 200 index has followed the lead of U.S. markets and is charging higher on Thursday. At the time of writing the benchmark index is up 1.5% to 6,423.1 points. Four shares that are climbing more than most today are listed belo...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced the initiation of a trial for the treatment of paediatric scald injuries with an enrollment of the first patient in the US.

In morning trade the AVITA Medical Ltd (ASX: AVH) share price has been storming higher. At the time of writing the regenerative medicine company’s shares are up 7% to 66.5 cents. Why is the AVITA Medical share price storming higher? As wel...

In early afternoon trade the S&P/ASX 200 index is trading notably lower. At the time of writing the benchmark index is down 1.2% to 6,357.2 points. Four shares that have not let that hold them back are listed below. Here’s why they are...

Bone healing biotech company Osteopore (ASX: OSX) has posted strong revenue growth since its ASX debut, eyeing China and the US as the next markets for its regenerative technology. The Australian and Singapore-based business listed on the...

Whilst today’s market selloff is disappointing, it is worth remembering that even after today’s sea of red, the share market is still up significantly over the last 12 months. For example, since this time last year, the S&P/ASX 200 ind...

By Michael Gable  Despite the coronavirus, the US share market has made another all-time high, and the Australian market has been consolidating the gains from early January in an orderly fashion. Materials and Energy stocks remain a bit ris...

While the S&P/ASX 200 Index (INDEXASX: XJO) ended the day slightly down, here are 3 ASX shares that have shown strong upward share price movement today. AVITA Medical Ltd (ASX: AVH) After rocketing as much as 7.5% in mid-afternoon tr...

Spray-on-skin maker Avita has had runaway success on the ASX. And it's not done yet, says Morningstar's Nicolette Quinn.

The Polynovo Ltd (ASX: PNV) share price has been on a tear this year, up more than 56% so far. In December, sales of the company’s NovoSorb BTM product cracked $2 million for the first time, a 134% increase over the previous December. Nov...

By Greg Peel Second Leg Wall Street had used the excuse of solid earnings results and a better than expected GDP performance to turn around an initial fall on Thursday night into a rally on the close. Traders were not letting coronavi...

In afternoon trade the S&P/ASX 200 index is on course to finish the week on a positive note:. At the time of writing the benchmark index is up 0.3% to 7,031.1 points. Four shares that have climbed more than most today are listed below....

The AVITA Medical Ltd (ASX: AVH) share price has been a strong performer on Friday. In afternoon trade the global regenerative medicine company’s shares are up 6.5% to 68.2 cents. This makes AVITA the second-best performer on the ASX 200 i...

A choppy week looked set to end with an uplift as the share market recouped yesterday’s losses following a late reversal on Wall Street. The ASX 200 bounced 17 points or 0.2 per cent to 7025 this morning, but remained on track for its fi...

The GUD Holdings Limited (ASX: GUD) share price is on course to end the week on a positive note. In afternoon trade the diversified products company’s shares are up 6% to $11.87. This makes it the third-best performer on the ASX 200 index...

The Australian market lost yesterday’s gains as the number of reported coronavirus cases nears 8000 and impacts Asian markets. Despite morning gains, the ASX 200 trailed off just over an hour into the session. The benchmark index relin...

AVITA Medical (ASX:AVH) has announced that the US FDA has approved its application to conduct a feasibility study evaluating the safety and effectiveness of the RECELL Autologous Cell Harvesting Device for repigmentation of depigmen...

Investment site MarketIndex regularly aggregates the ratings of analysts from different brokerages to provide a market consensus on ASX shares. This consensus can be used to uncover ASX shares that warrant further investigation. Here are...

The PolyNovo Ltd (ASX: PNV) share price closed yesterday’s trading session more than 8% higher. Although there was no direct catalyst to prompt the share price move, it could be an indication of continued interest in the company. What does...

In 2019 the culmination of decades worth of work turned several biotechs and life sciences companies into overnight successes. As investors look to defensive growth stocks to compensate for a sluggish economy and with expectations of more h...

It was a great year for ASX healthcare shares in 2019, with the S&P/ASX Healthcare Index increasing by 41%. These 3 ASX healthcare shares experienced even greater gains in 2019, but can they continue to outperform in 2020?  Avita Med...

In 2019, the S&P/ASX 200 (INDEXASX: XJO) increased nearly 22%. Avita Medical Ltd (ASX: AVH) was the star performer on the index, up more than 700% for the year. Polynovo Ltd (ASX: PNV), EML Payments Ltd (ASX: EML), and Fortescue Metals...

The S&P/ASX 200 index was in fine form in 2019, ending the year with a return of just over 20% excluding dividends. Whilst the majority of shares on the index raced higher, a number climbed more than most. Here’s why these were the bes...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Monday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.25% to 6...

Avita Medical (AVH) has received FDA approval to conduct a feasibility study evaluating its Recell device Recell is used to deliver pigment to lesions affected by vitiligo Vitiligo is a disease resulting in the loss of pigmentation in pa...

30 Dec 2019 - AVITA Medical (ASX:AVH, NASDAQ:RECEL) has announced the resignation of joint company secretary Tamara Barr and secured US FDA approval to conduct a feasibility study …

The AVITA Medical Ltd (ASX: AVH) share price will be on watch on Monday after the release of a positive announcement. What did AVITA announce? This morning AVITA announced that the U.S. Food and Drug Administration (FDA) has approved the c...

The year is nearly over, so I think it’s time to look back at some of the shares that could be called shares of the year. A special shout-out must go to Avita Medical Ltd (ASX: AVH) and Opthea Ltd (ASX: OPT) as two of the best performers o...

At every investor presentation – and he’s fronted a few – Avita Medical (ASX:AVH) chief executive Dr Mike Perry includes a before-and-after picture of the visage of a 12-year-old girl who suffered burns to two-thirds of her body when her fa...

Why do investors consider having diversified stocks? The most crucial principle of investing is to have a variety of stocks in the portfolio. This would imply the investors investing their money in different types of stocks, so that they ar...

The stock markets are sensitive to the macro-economic environment as well as to the health of global economy. If global growth comes into question, the stock markets might witness unfavourable impacts. Let us now have a look at performance...

The S&P/ASX 200 index closed lower, down by 18.3 points or 0.27 per cent at 6,833.1 points relative to the last close. And, the All Ordinaries index closed lower by 0.21 per cent or 14.4 points to close at 6,942.6 points. Some of the b...

Being the most dynamic industry, in the health care sector, there is always a need for innovation to develop new therapies, medical devices as well as diagnostic solutions for patients. Medical device and pharma & biotech companies are...

At lunch on Wednesday the S&P/ASX 200 index is struggling once again. At the time of writing the benchmark index is slightly lower at 6,843.4 points. Here’s what has been happening on the market today: NAB tumbles. The National Austral...

Earlier today I looked at three ASX 200 shares that have been smashed in 2019. Thankfully, these shares are in the minority, with the majority of shares on the index recording solid gains this year. Three ASX 200 shares that are leading th...

With the year coming to a close, I thought it would be interesting to look at 2019 in terms of some of the movements we saw in the ASX300 and its constituents. While there are still 2 weeks to go, we enter 2020 vastly different to how we st...

The Opthea Ltd (ASX: OPT) share price has been one of the best performers on the All Ordinaries in 2019. Since the start of the year the shares of the developer of novel biologic therapies for the treatment of eye diseases have gained a ma...

The S&P/ASX 200 index closed lower, down 23.1 points or 0.34 per cent at 6,706.9 points relative to the last close. The All Ordinaries index was lower by 0.36 per cent or 24.3 points to close at 6,812.1 points. Some of the best & w...

At lunch on Tuesday the S&P/ASX 200 index is trading ever so slightly higher. The benchmark index is up a few points to 6,732.5 points at the time of writing. Here’s what has been happening on the market today: Bank shares lower.   The...

The introduction of innovative technologies in the health care sector has entirely transformed the industry and has appeared as a boon for patients, clinicians, researchers and scientists.  Health care expenditure is increasing at the globa...

The S&P/ASX 200 index closed higher, ending 23 points or 0.34 per cent higher at 6,730 points relative to the last close. The All Ordinaries index was higher by 0.33 per cent or 22.9 points to close at 6,836.4 points. Some of the best...

Capital growth occurs when share prices to increase in value, and in 2019 we have seen some shares soar to new heights. Here we take a look at 3 ASX shares that have tripled in value (or more) in 2019. WISR Ltd (ASX: WZR) Currently trading...

Carrie LaFrenz published an article in the Australian Financial Review discussing how Avita Medical’s spray-on skin product is revolutionising care for burn patients. Carrie draws on Joseph’s comment that they are right on path with the rei...